Resources from the same session
LBA2 - Assessment of Ki67 and FOXC1-based response predictor tracking proliferation and plasticity as a complementary diagnostic for neoadjuvant Olaparib+Paclitaxel+Darvalumab in primary triple negative breast cancer: retrospective analysis of the I-SPY2 Trial
Presenter: Partha Ray
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
1MO - Prognostic and biologic significance of HER2-low expression in early breast cancer
Presenter: Paolo Tarantino
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
2MO - Development of a prognostic gene-expression signature for early stage HER2-positive breast cancer patients
Presenter: Serena Di Cosimo
Session: Mini Oral session 3
Resources:
Abstract
Slides
3MO - Association of the research-based HER2DX signatures with survival in early-stage triple-negative breast cancer (eTNBC)
Presenter: Benedetta Conte
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA2, 1MO, 2MO and 3MO
Presenter: Carmen Criscitiello
Session: Mini Oral session 3
Resources:
Slides
Webcast